Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus propofol + etomidate for hemodynamic response to tracheal intubation
IRCT20120215009014N536Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Propofol + etomidate with Propofol (2 arms). Primary endpoints: Heart rate, Systolic blood pressure and 2 more. Started Dec 2024; status: completed.
02
Drugs
propofoletomidate
Beyond the preview
Go deeper on IRCT20120215009014N536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N536.